Archive | COVID-19

Covid-19 vaccination challenges

Covid-19 vaccination challenges

Should we shame and pressure people to take the [“experimental”?] Covid vaccine?

Part 109/2021 (Contribution)

BRADES, Montserrat, February 28, 2021 – On Wednesday, February 23, Montserrat’s Chief Medical Officer Dr. Greenaway-Duberry unexpectedly appeared in our media. She announced that based on new findings, it is now recommended that the second dose of the Oxford/AstraZeneca vaccine for Covid-19 should be taken eight weeks after the first dose, as that gives a superior result to the previously recommended four-week point. This puts several questions on the table, starting with: just how experimental is the cluster of emerging Covid-19 Vaccines?

A key clue is found in a February 12, 2021, Gina Hawkins report on Military dot com, “Navy Will Make COVID-19 Vaccination Mandatory ‘As Soon as We Can:’ 3-Star Admiral” which cites Vice Admiral Andrew Lewis, U.S. Second Fleet Commander and US Defense Department Officials:

“ ‘We cannot make it mandatory yet,’ [Admiral] Lewis said. ‘I can tell you we’re probably going to make it mandatory as soon as we can, just like we do with the flu vaccine’ . . . . Defense Department officials have previously said that the COVID-19 vaccine would remain voluntary while it’s under emergency-use authorization by the Food and Drug Administration. That designation is expected to last up to two years while the FDA assesses the vaccination’s efficacy and side effects.”[1]

Taking account of testing already undertaken in recent months, this tells us that it may take up to two or three years “[to] assess . . . efficacy and side effects.” That easily explains why our CMO has had to make a change in the recommended waiting time to take our booster shots: globally, we are still studying and learning about the vaccine, the “science” has not settled down yet.

In a related Defence dot gov  report, “Military, Medical Leaders Discuss COVID-19 Issues With Service Members,” Terri Moon Cronk cites[2] US Army General and then Chairman of the Joint Chiefs of Staff, Mark A. Milley, who:

“. . . noted that the National Institutes of Health and the Food and Drug Administration have declared the vaccines as “safe and highly effective” but he acknowledged that getting the vaccine is a personal decision. “We . . .  encourage you to consult your primary care physician to address any concerns . . .  so you can be well-equipped to make the right decision for you and your family,” Milley said. “Protect yourself, protect your families and protect our communities. Together, we can all lead the way for the nation in the fight against COVID-19.”

We see here a clear recognition that while there is good evidence of vaccine effectiveness, we are responding to a global, fast-moving pandemic and are strictly speaking still in a somewhat exploratory phase of testing and evaluating the vaccines. The challenge being faced by officials here and overseas is that the epidemic is outracing the usual pace of new drug development, testing and certification so it is necessary to act on good enough but not complete evidence, in hopes of saving lives, net.

But what about the AstraZeneca vaccine in use here?

A copy of the official “Product Information as approved by the CHMP on 29 January 2021, pending endorsement by the European Commission,” tells us:

“COVID-19 Vaccine AstraZeneca is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older.  The use of this vaccine should be in accordance with official recommendations . . . . The safety and efficacy of COVID-19 Vaccine AstraZeneca in children and adolescents (less than 18 years of age) have not yet been established. No data are available . . . .Appropriate medical treatment and supervision should always be readily available in case of an anaphylactic event [i.e. strong allergic reaction] following the administration of the vaccine. Close observation for at least 15 minutes is recommended following vaccination. A second dose of the vaccine should not be given to those who have experienced anaphylaxis to the first dose of COVID-19 Vaccine AstraZeneca . . . . The duration of protection afforded by the vaccine is unknown as it is still being determined by ongoing clinical trials . . . . Currently available clinical trial data do not allow an estimate of vaccine efficacy in subjects over 55 years of age.” 

In short, the AstraZeneca vaccine is also still being evaluated through “ongoing clinical trials.” It is credibly effective but clearly, points of concern remain. Therefore, we should recognise that while it is generally advisable to take it, any significant medical treatment should be taken under the advice of a doctor familiar with one’s medical history and current circumstance. That is simple, basic medical ethics and professional standards. (That’s part of why when we first go to a doctor she or he will normally take our general medical history, blood pressure etc. and will set up a patient file.)

Similarly, it is common sense that people prone to strong allergic reactions or who have significant medical challenges should be extra careful to get advice from their doctor.

Finally, what about “herd immunity”?

It is commonly reported that the AstraZeneca vaccine is about 70% effective.[3]  Where, we can see from a Healthline dot com article by Noreen Iftikhar, MD, “What Is Herd Immunity and Could It Help Prevent COVID-19?”[4] that:

“For some diseases, herd immunity can go into effect when 40 percent of the people in a population become immune to the disease, such as through vaccination. But in most cases, 80 to 95 percent of the population must be immune to the disease to stop its spread.  For example, 19 out of every 20 people must have the measles vaccination for herd immunity to go into effect and stop the disease. This means that if a child gets measles, everyone else in this population around them will most likely have been vaccinated, already have formed antibodies, and be immune to the disease to prevent it from spreading further.”

“Herd immunity” happens when on average an infected person is so unlikely to pass the disease on to someone without antibodies that it begins to “die out.”  That can come from enough people catching then recovering from a disease, or from vaccination. Now, we know that Covid-19 is fairly contagious so the 80% estimate some have suggested is reasonable. But if 100% of our population is vaccinated with a vaccine estimated to be 70% effective, then by simple Arithmetic we cannot make the 80 – 95% of population threshold; herd immunity may not be achievable using AstraZeneca, not only from “doing our sums” but especially as we can see that it is not recommended for children under 18

Where, too, the other vaccines that are said to be 90+% effective in immunising (Moderna, Pfizer), are based on novel technologies never before used with people. That means they are far more experimental than AstraZeneca.

Obviously, there is room for different opinions and for different people to make up their minds on the balance of medical risks they face given issues such as allergic reactions.


[1]           See: https://www.military.com/daily-news/2021/02/12/navy-will-make-covid-19-vaccination-mandatory-soon-we-can-3-star-admiral.html

[2]           See https://www.defense.gov/Explore/News/Article/Article/2493366/military-medical-leaders-discuss-covid-19-issues-with-service-members/

[3]           For example, see https://inews.co.uk/news/uk/covid-vaccine-how-effective-astrazeneca-pfizer-moderna-vaccination-efficacy-compared-what-meaning-845136

[4]           See https://www.healthline.com/health/herd-immunity

Posted in COVID-19, De Ole Dawg, Health, International, Local, News, Regional, Science/Technology0 Comments

AccuWeather

St. Vincent and the Grenadines volcano erupts, prompts thousands to evacuate – an update

AccuWeather
AccuWeather

https://www.accuweather.com/en/weather-news/st-vincent-volcano-erupts-prompts-thousands-to-evacuate/929927

By Courtney Travis, AccuWeather senior meteorologist

Updated Apr. 12, 2021, 7:48 AM AST Copied

Hours after an initial eruption of the La Soufriere volcano on the Caribbean island of St. Vincent, a second explosion was reported, resulting in a massive plume of smoke and ash.

The largest volcano on the Caribbean island of St. Vincent erupted on Friday in spectacular fashion, sending an ash plume shooting an estimated 52,000 feet into the atmosphere and forcing the evacuation of thousands.

Through the weekend, much of the island was covered in ash from the eruptions that continued on through Friday night. By Sunday night, eruptions were firing up again as conditions worsened.

Dozens of residents required rescuing from the northern part of the island as the new dangers place even more islanders at risk.

A man rides his bicycle along the main Black Rock road, covered with ash coming from the eruption of La Soufriere volcano in the neighboring island of St. Vincent, on the outskirts of Bridgetown, Barbados, Sunday, April 11, 2021. (AP Photo/Chris Brandis)

Richard Robertson, a geologist with the University of the West Indies Seismic Research Centre, said during a Sunday night news conference that there is evidence of pyroclastic flows, the rush of super-heated gas and debris traveling down the mountainside as fast as 120 miles per hour, in the areas around the volcano, NPR reported.

“These flows are really moving masses of destruction,” Robertson said. “They just destroy everything in its path. Even if you have the strongest house in the world, they will just bulldoze it off the ground.”

The abrupt eruptions continued to launch debris and a cloud of ash into the air throughout Sunday night, leaving its remnants scattered throughout the island.

On Saturday, he said the roughly 110,000 residents of St. Vincent, many of whom have already sought refuge on other islands, should expect to see the largest blast of their lifetimes in the coming days

“The explosive eruption has started and it is possible you could have more explosions like these,” he said during a press conference on Saturday, according to NPR. “The first one is not necessarily the worst one, the first bang is not necessarily the biggest bang this volcano will give.”

https://twitter.com/NWSElPaso/status/1381084579616985088?s=20

Very early Sunday morning, the National Emergency Management Organization of St. Vincent and the Grenadines (NEMO SVG) said on Twitter that a “massive power outage” was underway following another “explosive event” of the volcano. The island-wide power outage began just after 1 a.m., local time, on Sunday morning as loud rumblings continued to emit from the volcano, according to News 784 in St. Vincent.

The Prime Minister of St. Vincent and the Grenadines, Ralph Gonsalves said water supplies to most of the island had been cut off and its airspace had been closed due to the smoke and plumes of volcanic ash moving through the atmosphere, according to the BBC.

St. Vincent is a volcanic island located in the Lesser Antilles of the Caribbean and is home to La Soufrière, its largest volcano.

Around 8:30 a.m., local time, on Friday, the volcano underwent what the scientists at the University of the West Indies (UWI) Seismic Research Center called an “explosive eruption,” spewing ash high into the air.

The NEMO SVG reported later in the morning that the ash plume had reached about 5 miles (8 km) into the air, and ash had fallen at Argyle International Airport. A NOAA-SSEC satellite estimated that the ash traveled an astonishing 52,000 feet into the atmosphere, or about 10 miles up.

Photo from the explosive eruption that occurred at La Soufriere, SVG at 8:41 a.m. local time. Ash has begun to fall on the flanks of the volcano and surrounding communities including Chateaubelair and Petite Bordel. (Photo/UWI Seismic ReasearchCentre)

The explosion of ash was so large that it was visible from space on weather satellites. Southwesterly winds carried the cloud of ash over northern parts of St. Vincent and over the waters of the western Atlantic Ocean between the islands of Saint Lucia and Barbados.

NEMO reported that the ash was extending at least 20,000 feet (more than 6 km) to the northeast of the volcano.

This GOES-16 true-color satellite loop shows what the La Soufriere volcano eruption looked like from space on the morning of April 9, 2021 (GOES-16/NOAA)

Geologist Richard Robertson told News 784 in St. Vincent on Friday that the volcano had returned to a quieter period, but more eruptions are expected to follow.

A second eruption occurred later Friday evening, NEMO reported, jettisoning ash over 2 miles into the atmosphere.

Ash venting resumed at La Soufrière at around 2:45 p.m. local time, the UWI Seismic Research Center reported Friday evening, and lightning could be seen in the ash column. Continuous tremors have been recorded since 3 p.m., and the center noted that the volcano continues its explosive phase which may last several days to weeks.

Friday afternoon, lightning was visible in the volcano’s ash column due to its highly charged nature. (Photo/UWI Seismic Research Centre)

”If there is a much bigger explosion, the ash can spread further to the south,“ Robertson said, adding that, “This could continue for days or weeks, and monitoring will continue.”

The UWI Seismic Research Center first noticed gases spewing from the dome of the volcano on Thursday morning.

As seismic activity continued and became more intense, with magma visible near the surface later on Thursday, the country’s National Emergency Management Organization raised the island’s alert level from orange to red, according to NPR, meaning that eruption was considered “imminent”.

Smoke spews from the glowing dome of the La Soufriere volcano in Saint Vincent and the Grenadines on Thursday, April 8, 2021 (right), and the resulting eruption (left) on Friday, April 9, 2021. (Photos/The UWI Seismic Research Centre)

Around 6:00 p.m. Thursday, Gonsalves announced in a press conference the evacuation order for residents in “red zones” on the northeast and northwest sides of the island.

This evacuation includes roughly 16,000 people on the island, according to WFAA, a WABC affiliate in Dallas, Texas.

Government-led evacuations immediately began, but they were to be assisted by nearby cruise line ships, arriving Friday, to help get people to safety.

However, given the ongoing COVID-19 pandemic, evacuations are more complicated than usual.

CLICK HERE FOR THE FREE ACCUWEATHER APP

Gonsalves said in his press conference that people have to be vaccinated before boarding a cruise ship or to go to another island. The minister also highly recommended those taking shelter in Saint Vincent be vaccinated.

Flights were cancelled at the Argyle International Airport on St. Vincent as well as the Grantley Adams International Airport on the nearby island of Barbados on Saturday, further complicating evacuation efforts.

Even on Friday morning, fresh magma near the surface of the volcano left the sky aglow.

https://www.facebook.com/uwiseismic/photos/a.112065204326/10158019592044327/?type=3

According to CNN, the La Soufrière volcano on St. Vincent has had five explosive eruptions in the past, with the most recent being 1979. There was, however, an uptick in seismic activity more recently in December of 2020.

Gonsalves urged people to be patient and continue to take precautions as experts warned that explosive eruptions from the volcano could continue for days or even weeks, NBC News reported.

In an interview with NBC Radio, Gonsalves said that it could take up to four months for life to return to normal, depending on the extent of the damage. He added that agriculture will be badly affected.

In extremely powerful volcanic eruptions, the ash and aerosols released in the eruption can pass through the troposphere, the lowest layer of Earth’s atmosphere, and penetrate into the stratosphere, the second layer of the atmosphere.

If enough of the ash and other pollutants released in the eruption make it into the stratosphere, they can influence the climate around the globe. The boundary between the troposphere and stratosphere is about 6 miles (10 km) above the ground, a little higher than where commercial jets typically fly.

Posted in Business/Economy/Banking, CARICOM, Climate/Weather, Climate/Weather, COVID-19, Environment, Featured, Features, International, Local, News, OECS, Photos, Regional, Volcano0 Comments

New Side Effects With AstraZeneca and Janssen COVID-19 Vaccines?

New Side Effects With AstraZeneca and Janssen COVID-19 Vaccines?

New Side Effects With AstraZeneca and Janssen COVID-19 Vaccines?

TMR is not suggesting to anyone not to access COVID-19 ‘vaccines’. Merely providing information to those who may be at risk, knowingly or otherwise, to be aware that there ARE varying life-threatening risks and to consider and consult, before becoming a ‘negative/positive statistic, all the theories, conspiratorial, truths taken on board. We encourage there is not an earlier time available for everyone to take stock of their health and immunise themselves against all poor health lifestyles.

Medscape Logo
Medical Newsreprint

by Sue Hughes

April 09, 2021

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

In addition to the unusual blood clots linked to the AstraZeneca COVID-19 vaccine, which have received extensive attention in the past couple of weeks, other safety signals are also being investigated with this vaccine, and now with Johnson & Johnson’s Janssen vaccine as well, the European Medicines Agency (EMA) reports.

Highlights of the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) meeting April 6-9 include that the agency has started a review of a safety signal to assess reports of capillary leak syndrome in people who were vaccinated with Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).

It also reports that PRAC has started a review of a safety signal to assess reports of thromboembolic events with low platelets in people who received the COVID-19 Vaccine Janssen.

Capillary Leak Syndrome with AZ Vaccine

An EMA press release issued today notes that five cases of capillary leak syndrome, characterized by leakage of fluid from blood vessels causing tissue swelling and a drop in blood pressure in individuals receiving the AstraZeneca vaccine, were reported in the EudraVigilance database.

“At this stage, it is not yet clear whether there is a causal association between vaccination and the reports of capillary leak syndrome. These reports point to a ‘safety signal’ — information on new or changed adverse events that may potentially be associated with a medicine and that warrants further investigation,” the EMA states.

PRAC will evaluate all the available data to decide if a causal relationship is confirmed or not, it adds.

Thromboembolic Events with J&J/Janssen Vaccine

Four serious cases of unusual blood clots with low blood platelets have been reported postvaccination with COVID-19 Vaccine Janssen, EMA reports. One case occurred in a clinical trial and three cases occurred during the vaccine rollout in the US. One of them was fatal.

COVID-19 Vaccine Janssen is currently only used in the US, under an emergency use authorization. COVID-19 Vaccine Janssen was authorized in the EU on March 11. The vaccine rollout has not started yet in any EU member state but is expected in the next few weeks.

The Janssen vaccine uses an adenovirus vector, as does the AstraZeneca vaccine.

PRAC is investigating these cases and will decide whether regulatory action may be necessary, which usually consists of an update to the product information, it adds.

For more news, follow Medscape on Facebook, Twitter, Instagram, YouTube, and LinkedIn

Additional ‘educational’ reading: https://www.medscape.org/viewarticle/948301

Posted in Business/Economy/Banking, COVID-19, Education, International, Local, News, Opinions, Regional, Science/Technology0 Comments

Corona-virus-tidbits-19

Dr. Ryan Cole speaks, Vitamin D, Ivermectin, “Vaccines” re COVID-19

TMR research for over a year of questioning as high up to the world stage of briefings from WHO/PAHO/CARPHA, about the message to be given to COVID-19, its prevention by building immunity, and treatment that can mitigate the sufferings the virus brings; to the alternative to the suspicious and far from full protection from the experimental vaccines; brought us to this video: Vitamin D, Ivermectin, “Vaccines” https://www.bitchute.com/video/5UHDpnt6ZYrp/ – following our several Facebook posts at –https://www.facebook.com/themontserratreporter.
Dr. Ryan Cole speaking on Vitamin D, Ivermectin, “Vaccines”
Dr. Ryan Cole is the CEO and Medical Director of Cole Diagnostics, one of the largest independent labs in the State of Idaho. Dr. Cole is a Mayo Clinic-trained Board Certified Pathologist.

This summary provides:

<<The current CDC and NIH recommendation: “Go home and isolate; if you can’t breathe or your lips turn blue, then go to the hospital” (this amounts to apathy, not treatment, as physicians are trained to treat people at the first instance of a disease/pathogen).

The earlier the treatment, the more complications that can be avoided over time (simple common sense).

If there is a treatment extant for a disease, then the federal government cannot approve a vaccine [for Emergency Use Authorisation by law . . . .

Six months ago, the World Health Organization said to “stop using Remdisivir because it doesn’t add survivability to any patients” (the drug only works during the first 2-3 days of infection).

Yet, many US hospitals still administer the drug at $3,000 per dose long after initial infection when the virus has already massively replicated.

Convalescent plasma also only works during the first 2-3 days when the virus is replicating (only obtained in the hospital when the treatment is no longer effective).

Monoclonal antibodies also only work during the first couple of days with the disease.

Administering steroids at the right point in the disease (during an inflammatory state) does add survival benefit.

Ivermectin (an anti-parasitic given to horses and dogs) is an effective prevention and treatment therapy.

Although an anti-parasitic, Ivermectin also is a phenomenal anti-viral prophylaxis and can be used for early treatment, immune modifier treatment during hospitalization, and post-COVID “long hauler” treatment.

Ivermectin is safe, effective, and INEXPENSIVE, having been taken by 4 billion people since the 1980s (it is on the world’s most essential drugs list!).

In Petri dish studies conducted, in August 2020, Ivermectin was found to have killed 99% of the virus, but the NIH recommended against its use.

Ivermectin has been given in the past to humans at 30-40 times the recommended dosage with no adverse effect (only two humans have ever been determined to have died after using the drug, and they had a rare immunodeficiency disease).

A few Ivermectin studies are finally being conducted independently in the US in Texas, Florida, and Wisconsin hospitals (results: they have decreased their COVID death rates by 70-90%!).

In Houston, one hospital was using it; now, all hospitals in Houston administer the drug.

It is an approved medicine, but it is off-label (approved for other uses) because the FDA has not approved its use to treat the virus because studies haven’t been completed on Americans – the FDA doesn’t use foreign studies to approve drugs).

However, Pfizer received FDA approval for its experimental vaccine based on tests on foreign subjects, not Americans (!).

In meta-analysis of 15,000 patients, Ivermectin – if added to the treatment plan, no matter what that plan is – reduces the death rate by at least 75% (up to 86% if given early) . . .

A full course of Ivermectin treat costs under $30.

Fully 100% of the world’s Ivermectin trials have shown benefits (details provided in the video presentation):

    Decreases disease acquisition by 88-100%.

    Decreases viral replication and shedding time by half.

    Decreases disease course and severity by 80-90%.

    Decreases disease death rate by 75% and up to 86% if administered early in treatment.

Ivermectin is the only medicine that has shown benefit in 100% of world trials conducted>>

Posted in Business/Economy/Banking, COVID-19, Featured, Features, International, Local, News, Regional, Science/Technology0 Comments

No photo description available.

St. Vincent and the Grenadines was preparing for the eruption of La Soufriere volcano

St. Vincent and the Grenadines, preparing for the eruption of La Soufriere volcano

EMERGENCY SHELTERS FOR A VOLCANIC ERUPTION (EXPLOSIVE)

 28th March 2021

https://www.google.com/maps/d/viewer?mid=1RjQeofFX46htCMxbnyArqfxxCSOkbD70&ll=13.25264487913983%2C-61.1971605&z=11

National Emergency Management Organisation (NEMO)

EMERGENCY SHELTERS FOR A VOLCANIC ERUPTION (EXPLOSIVE)

LA SOUFRIÈRE BULLETIN #56 APRIL 10, 2021 5:00 P.M

LA SOUFRIÈRE BULLETIN #56 APRIL 10, 2021 5:00 P.M 

  1. The seismic tremor generated by voluminous energetic venting of La Soufrière Volcano continued overnight.

Volcanic Hazard Zones

April 2021 S M T W T F S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

Weather Forecast

Meteorological Services, Argyle

10 April 2021

10 April 2021

Press/News Release

No photo description available.

Posted in Business/Economy/Banking, CARICOM, Climate/Weather, Climate/Weather, Columns, COVID-19, Environment, Featured, Health, International, Local, News, OECS, Police, Regional, Volcano0 Comments

Spring breakers flock to Florida beaches

‘Impending doom’: Why the US is facing a new coronavirus wave despite one of the world’s best vaccine programmes

Reprint

By Jamie Johnson, US correspondent, Washington 30 March 2021

Hospitalisations are increasing and deaths are multiplying from the disease that has already killed 550,000 people in the US By Jamie Johnson, US correspondent, Washington 30 March 2021

Joe Biden, the US President, has urged states to pause their reopening efforts after a senior health official warned of the “impending doom” of a deadly third wave of coronavirus cases.

Despite a hugely successful vaccine programme – one in six Americans is already fully inoculated – cases are rising, hospitalisations are increasing, and deaths are multiplying from the disease that has already killed 550,000 people in the United States.

“We still are in a war with this deadly virus and we’re bolstering our defences. But this war is far from won,” said Mr Biden.

Dr Rochelle Walensky, the director of the US public health agency, the Centres for Disease Control and Prevention (CDC), appeared to fight back tears on Thursday as she said: “I’m going to reflect on the recurring feeling I have of impending doom.

“We have so much reason for hope, but right now I’m scared”.

As Boris Johnson warns that a third wave in the UK is still a risk, despite a successful vaccine programme, the US may be used as a barometer for how the situation in Britain could evolve.

How is the US vaccine rollout programme progressing?

While his administration ramps up its drive to administer jabs as quickly as possible, Mr Biden has said that 90 per cent of US adults would be eligible for vaccination by April 19, and 90 per cent of Americans would have a vaccination centre within five miles of their homes by then.

So far, 145,812,835 vaccine doses have been administered and 15.8 per cent of Americans are fully vaccinated.

On Monday, Texas, Kansas, Louisiana, North Dakota, Ohio and Oklahoma made all adults eligible for vaccination. New York said that all adults would be eligible starting April 6.

Mr Biden had pledged to administer 100 million vaccine shots in his first 100 days in office. That goal has since been revised to 200 million after the first was met within 60 days.

With more than 2.5 million jabs a day, it is widely accepted that the rollout is going well.

What is going wrong?

The number of new coronavirus cases jumped by seven per cent over the past week to a seven-day average of around 60,000 cases, according to the CDC.

Data from the New York Times shows that in nine states over the past two weeks, virus cases have risen more than 40 per cent.

Connecticut reported a 62 per cent jump over the past two weeks, and New York and Pennsylvania both reported increases of more than 40 percent.

Michigan saw a 133 per cent increase – and epidemiologists have pointed to indoor dining restarting on February 1 as being a possible root cause.

In Florida, which has started welcoming tourists, the situation is worsening.

Spring Breakers were forced to be inside by 8pm as the young partygoers appeared to give up on social distancing and mask-wearing in Miami during the holidays.

In Orange County, Orlando, the average age for new infections has dropped to 30 and one in three people hospitalised is under 45.

Spring breakers flock to Florida beaches
Spring Breakers were forced to be inside by 8 pm Credit: REUTERS

But there is a wider problem at play.

Over the past week, the state has averaged nearly 5,000 cases per day, an increase of 8 per cent from its average two weeks earlier.

Worryingly for the UK, the Kent strain is also rising exponentially in Florida, where it accounts for a greater proportion of total cases than in any other state, according to the CDC.

Case Study: Texas

Fewer restrictions do not automatically mean more cases, data from Texas appears to show.

In a controversial move on March 2, Governor Greg Abbott ended the state’s restrictions despite Texas recording about as many cases per day as the UK on average and having a population less than half the size.

“I just announced Texas is OPEN 100%. EVERYTHING. I also ended the statewide mask mandate.”

Mr Biden called it “irresponsible”

But the latest figures show that they may have got it right. According to New York Times data, over the past two weeks coronavirus infections in Texas have declined 17 per cent, deaths have declined 34 per cent and hospitalisations have declined 25 per cent.

One note of caution, however, is that the seven-day average of newly reported coronavirus infections was up on Sunday to 3,774. Last Wednesday, the average case count was at a low of 3,401.

What is being done to stop the spread?

The speedy vaccine operation is not moving fast enough to stop the spread of the virus and the President has criticised the “neanderthal thinking” of some state governors who have dropped the requirements for people to wear masks.

“The failure to take this virus seriously is precisely what got us into this mess in the first place,” said Mr Biden.

“I’m reiterating my call for every governor, mayor and local leader to maintain and reinstate the mask mandate.

Asked if states should pause re-opening efforts, Mr Biden said “yes.”

It is yet to be seen if the states will listen.

Mr. Biden has got off to a strong start and is polling well because he has tackled the two most pressing issues for Americans head-on – the economy and the pandemic.

A $1.9 trillion (with a T) relief package has seen cheques for $1,400 sent to the vast majority of households to help cover lost income and pay the bills, while the vaccine programme is moving at a pace.

Much as in the UK, American health officials have told the public to “stick with it.”

“I know you all so badly want to be done,” said Dr Walensky. “We are just almost there, but not quite yet.”

What could the UK learn?

The US has not had a slow-release – each state taking forging its own path out of lockdown. That is why the data looks different in some areas. But of those where public spaces are opened, the general correlation is that cases have again risen.

“Because the government has allowed some things to open up, people have viewed that as a good thing to do,” Dawn Misra, a professor of epidemiology and biostatistics at Michigan State University told the New York Times.

“This is a really tricky part of public health messaging. Just because you’re allowed to be in restaurants and other places do not mean they are safe.”

This should give the UK pause for thought.

In the UK, things are moving in the right direction. Sunday had the lowest number of newly recorded cases in six months, while there were no Covid-related deaths in the capital.

But the prospect of continued success may not remain in the Prime Minister’s hands.

A third wave

Boris Johnson said that Britain needs to “build our defences” against a third wave brewing in Europe for “when it comes” to the UK.

“What we don’t know is exactly how strong our fortifications now are, how robust our defences are against another wave,” he said, ominously.

Europe is struggling with the vaccine rollout, and cases are rising again.

Paris and parts of northern and southern France are one week into a lockdown which will last at least four weeks, in an attempt to stem a third Covid wave fuelled by contagious variants.

Italy and Germany have tightened their borders.

In the US, a third wave is also bubbling under the surface, as explained by the number of rising cases, even in states where masks and social restrictions are still stringent.

As restrictions lift the UK and the US will be relying on their vaccine programmes outrunning the new variants. Whether they can remains to be seen.

Joe Biden finished his press conference on Monday by saying: “Fight to the finish. Don’t let up now.”

In a tweet on Tuesday, Mr Johnson said: “The vaccine is our best route out of this pandemic and we must all do our part by taking the vaccine when it is offered to us.”

Major Israeli study finds Pfizer jab 94 percent effective in ‘real world’ use
https://www.telegraph.co.uk/global-health/science-and-disease/major-israeli-study-finds-pfizer-jab-94-per-cent-effective-real/

Posted in COVID-19, Health, International, Local, News, Politics, Regional, Science/Technology0 Comments

The-Telegraph-logo

Major Israeli study finds Pfizer jab 94 per cent effective in ‘real world’ use

Reprint (adapted)

By Paul Nuki, Global Health Security Editor, London
Feb 14 2021

Medical teams celebrate before receiving coronavirus disease (COVID-19) vaccines

The results, which were carefully controlled and cover 1.2m people, are better than expected and likely to improve as more data comes in The Telegraph · February 13

The Pfizer BioNTech vaccine achieves 94 percent efficacy after the second dose, according to the first major “real world” study to be published on the jab’s performance.

While promising data have been coming out of Israel for the last few weeks, the Clalit Institute for Research released results of the first detailed and controlled study yesterday (Sunday) covering 1.2 million vaccinated and non-vaccinated people. 

Clalit is the country’s biggest health care provider, covering over half of Israel’s population.

The study found there was a 94 percent decrease in the rate of symptomatic infection and a 92 percent decrease in the rate of serious illness in those vaccinated, compared to 600,000 who were not vaccinated. 

Significantly, vaccine efficacy was found to be maintained in all age groups, including those over 70 – an age group in which vaccine efficacy could not be evaluated in Pfizer’s original clinical trials due to there being too few in this age group who participated. 

Clalit reported high vaccine efficacy of 91 to 99 percent over a period of seven days or more after participants had received a second dose of vaccine and were deemed “fully vaccinated”. The researchers said they expected this to rise further as more data beyond seven days flowed in.

Prof. Ran Blitzer, director of the Clalit Research Institute, said: “It is clear that Pfizer’s Corona vaccine is most effective in real life one week after the second dose, just as found in the [original] clinical study.

“Furthermore, the trends we identify indicate that continued follow-up for additional weeks after the second dose will significantly increase the measured efficacy of the vaccine. In fact, in a preliminary examination, we identify even higher efficacy for the prevention of symptomatic and severe disease among the vaccinated after 14 days”.

Clalit is expected to publish its results in full over the next few weeks. Some expect it will also publish findings on the degree to which the Pfizer vaccine blocks transmission of the virus – and the rumour is that these data are also very positive.

Teasing out the real-world effectiveness of the vaccine has been difficult because of confounding factors including a third lockdown and violent surge of the virus in Israel.

The Clalit study overcame this by carefully matching each vaccinated individual studied with a non-vaccinated person with near-identical circumstances.

“The vaccinated group was tested against a control group of about 600,000 non-vaccinated people who were carefully adjusted so that each vaccinated person was tested in relation to an unvaccinated person similar to him in a long series of indicators such as risk level of infection, level of risk of developing a serious disease, health status and more”, said Clalit in a press statement.

“The creation of the control group was done dynamically so that people were deducted and moved between the groups if their immunization status changed over time. 

“This form of calculation, which produces a complete resemblance in time to the place and personal characteristics between the vaccinated and non-vaccinated at any given moment, allows to fully normalise the impact of events that happened in parallel – such as the effect of quarantine, and changing vaccine contraindications”.

There were no data published on the efficacy of the vaccine after the first dose. Most data coming out of Israel in recent weeks suggest the protective effect of the jab only really kicks in solidly after the second dose. 

Last week the BioNTech scientist behind the Pfizer vaccine warned that the gap between doses should not extend beyond six weeks.

Major Israeli study finds Pfizer jab 94 percent effective in ‘real world’ use
https://www.telegraph.co.uk/global-health/science-and-disease/major-israeli-study-finds-pfizer-jab-94-per-cent-effective-real/

Posted in Business/Economy/Banking, COVID-19, International, Local, News, Regional0 Comments

image-1

UK Covid deaths plummet as 58 fatalities and 4,751 cases are recorded

msnewslogo
Tammy Hughes and April Roach

https://www.msn.com/en-gb/news/newslondon/pm-covid-passports-may-not-be-possible-until-absolutely-everybody-offered-jab/vi-BB1eXpFD?ocid=msedgdhp&ocid=msedgdhp

The UK recorded another 58 Covid-19 deaths and 4,715 new cases on Saturday, according to official government figures.

It brings the total coronavirus death toll in the UK total to 126,573. Separate figures published by the UK’s statistics agencies show there have now been 149,000 deaths registered in the UK where Covid-19 was mentioned on the death certificate.

The total of Covid-19 infections since the pandemic began, now stands at 4,329,180.

The number of people who have been vaccinated in Britain edges closer to 30 million with 29,727,435 people having received their first dose.

A total of 3,293,517 people have had their second dose.

Speaking about the milestone of NHS England passing 25 million first jabs, Professor Stephen Powis, the NHS national medical director, said: “This is the latest major milestone showing rapid and targeted progress in getting people in England protected against coronavirus.

“Passing the 25 million mark is a remarkable achievement for NHS staff across the country who have jabbed more than half the adult population and are continuing to work carefully to identify those last remaining people in the top priority groups yet to get their jab and urging them to come forward.

“While supplies of doses will be tightened next month, anyone with a second jab booked should come forward, and our other top priority is to remind everyone who is aged 50 and older or who has an underlying health condition that their first jab is available to them, now and throughout April.”

It comes as Boris Johnson admitted that he was wary about prospects of rising coronavirus cases but said he sees “absolutely nothing in the data” to halt the easing of lockdown.

Scotland recorded six deaths from coronavirus and 563 positive tests in the past 24 hours, according to Scottish Government data.

The latest official figures bring the death toll under this measure – of people who first tested positive for the virus within the previous 28 days – to 7,578.

The deaths of two further people who previously tested positive for Covid-19 in Northern Ireland have been reported by the Department of Health.

Another 138 confirmed cases of the virus were also recorded in the last 24-hour reporting period.Read More

Covid mutations ‘will reinfect people every two to four years’

Brazil’s Covid deaths soar to nearly 4,000 a day

Revealed: Corrie’s Bill Roache’s secret Covid battle

Three UK businesses on how they’re now trading with Europe

Posted in COVID-19, International, Local, News, Regional0 Comments

image

England told to ‘hold its nerve’ ahead of easing of lockdown outdoors

PA Media
Reprint

 By Sam Blewett, PA Political Correspondent 

The nation has been warned not to “squander the gains” made against coronavirus ahead of a major easing of the lockdown to allow greater freedoms outside.

a woman sitting at a bus stop: (PA)

© Andrew Matthews (PA)

NHS England national medical director Professor Stephen Powis said that Covid-19 still has the capacity to “wreak more havoc and ill health on a significant scale”, citing concerns over new variants.

He issued the warning ahead of groups of up to six, or two households, being able to socialise in parks and gardens once more as outdoor sports facilities reopen and the stay-at-home order ends in England on Monday.

Earlier, Boris Johnson said he is wary of the prospect of rising coronavirus infection rates, but sees “absolutely nothing in the data” to halt the easing of the lockdown.

The Prime Minister acknowledged cases could again spiral as restrictions are relaxed but said the “key difference” this time is that the rise in prevalence should be “sufficiently mitigated” by the successful vaccine rollout.

Prof Powis said the prospects “look immeasurably brighter and more positive” but said that the easing “does not mean job done”.

“We’ve made enormous progress that we need to build on and not squander the gains we’ve made,” he wrote in the Sunday Telegraph.

“We need to hold our nerve and drive for the line, so everyone can get back safely and soon to our normal lives.”

Meanwhile, the UK was planning to offer 3.7 million jabs to Ireland, partly to help ease lockdown restrictions in Northern Ireland, according to the Sunday Times.

It would be the first time Britain exported jabs to the EU and the newspaper reported a Cabinet minister saying it would be a “poke in the eye” for Brussels amid a row over supplies.

The arrival of Moderna vaccines to the UK had been expected in spring, but the Mail on Sunday reported that the first 500,000 doses will arrive imminently in a boost for the rollout.

During a discussion at the Conservatives’ virtual spring forum on Saturday, the Prime Minister said that a “third wave” is being witnessed in parts of Europe, and “bitter experience” has taught him that this could hit the UK “three weeks later”.

But he added: “There’s lots of promising evidence that a lot of people who could be vulnerable are now protected against death and serious disease, that’s my hope, my hunch.”

Mr. Johnson remained optimistic that his road map to easing England’s restrictions can continue, saying there is a “good chance” of allowing non-essential retail reopening on April 12, when hairdressers are also earmarked to reopen.

“In just a few days’ time, I’m finally going to be able to go to the barbers,” he said in a subsequent speech.

“But more important than that, I’m going to be able to go down the street and cautiously, but irreversibly, I’m going to drink a pint of beer in the pub.

“And as things stand, I can see absolutely nothing in the data to dissuade me from continuing along our road map to freedom, unlocking our economy, and getting back to the life we love.”

chart, histogram: (PA Graphics)

© Provided by PA Media (PA Graphics)

Government data up to Friday showed that 29,727,435 people in the UK have received a first jab, a rise of 411,305 on the previous day.

The Government said a further 58 people had died within 28 days of a positive test for Covid-19 as of Saturday, bringing the UK total to 126,573.

In Wales, lockdown restrictions were eased when the “stay local” requirement was dropped on Saturday, and people were allowed to stay in self-contained holiday accommodation.

A relaxing of England’s lockdown will take place on Monday when the “stay home” order ends, and groups of up to six people, or two households, are able to meet outside.

Posted in Business/Economy/Banking, COVID-19, Health, International, Local, Obituaries, Regional0 Comments

Vaccine

Ministry of Health Intensifies Vaccination Efforts, but without necessary caution

Vaccine
Just 11 cases were found of serious blood clots in 11 million jabbed with AZ in EU (Image: GETTY)

In an effort to convince and ‘gouge’ residents of Montserrat to access the COVID-19 Astra Zeneca vaccine the Ministry of Health stated: “The latest trials conducted in the United States of America, Chile and Peru by experts from Columbia University and the University of Rochester found the Astra Zeneca vaccine to be 100% effective at preventing people from falling seriously ill…”

The latest headline following a hold up and near ban of the vaccine in the European Union came as follows: “EUROPEAN countries were ordered to get on with the Oxford vaccine rollout after EU health chiefs declared it safe to use,’ saying what the UK Prime Minister continued as he addresses the risk and cautiousness about the vaccine on a whole. He basically encouraged, that while there may be risks (supporting what can be found on the UK website on COVID-19) what the EU bloc’s medical regulator the EMA said: “This is a safe and effective vaccine protecting people from COVID-19, with the associated risks of death and hospitalisation outweighing the risks.”

Meanwhile, the UK’s drug regulator has urged people to seek medical help if they experience headache for more than four days after getting vaccinated.

The question jumps out as to why is the Ministry continually touting this inaccurate information rather that being transparent and giving the information that guide the vulnerable from doing something they would otherwise be at least more cautious about.

EMA Emer Cooke
EMA declares AstraZeneca vaccine safe (Image: EMA•GETTY)

In a release dated March 22, 2021, The Ministry of Health and Social Services announced plans to implement a mobile vaccination clinic on Tuesday, March 23, 2021, in the parking lot of the Bank of Montserrat. This move comes as part of the Ministry’s efforts to increase vaccine uptake as the end date for first time vaccinations approaches.

The released informed that “March 31, 2021 has been earmarked as the closing date for first time vaccinations. Ministry of Health officials noted that the date was selected to ensure persons can receive their first and second doses of the vaccine before the batch expires.”

Regarding the initiative for tomorrow, officials noted that; “in February enough vaccines were received for 1,500 persons. Presently 1,188 persons have registered meaning 318 persons can still receive both doses of the vaccine. The Ministry of Health wants to ensure that no dose of the vaccine goes unused. Therefore all opportunities are being utilized to ensure that persons have easy access to vaccination.”

The main intention of Tuesday’s mobile vaccination clinic is to capture those individuals who want to be vaccinated but have not yet had the opportunity to register. Those persons can visit the Bank of Montserrat during the hours of 9:00 A.M to 12: 00 P.M and receive the vaccine. Persons who are scheduled to receive their second dose can also do so at the mobile clinic.

The Ministry of Health is encouraging all residents who wish to be vaccinated to visit the mobile clinic.  The vaccine is safe and effective. The latest trials conducted in the United States of America, Chile and Peru by experts from Columbia University and the University of Rochester found the Astra Zeneca vaccine to be 100% effective at preventing people from falling seriously ill and found no safety issues regarding blood clots.

The UK Prime Minister Boris Johnson reassured the Britons, saying: “The Oxford jab is safe and the Pfizer jab is safe. The thing that isn’t safe is catching COVID which is why it’s so important that we all get our jabs as soon as our turn comes.

Director Emer Cooke insisted the 11 million Britons that have received it should not have concerns over its safety. “This is a safe and effective vaccine protecting people from COVID-19, with the associated risks of death and hospitalisation outweighing the risks,” she told an online news conference. she told an online news conference.

The drugs watchdog was forced to publish evidence after 17 EU nations paused their AstraZeneca vaccine rollout over unproven fears it causes blood clots.

So now comes this just before we publish: AstraZeneca vaccine: UK regulator issues warning about headaches – seek medical attention
https://www.express.co.uk/life-style/health/1411764/astrazeneca-vaccine-side-effects-headache-blood-clots

Please visit TMR Facebook page for much information from many sources to deal with the COVID-19 pandemic and the pushover vaccine programs: https://www.facebook.com/themontserratreporter

Posted in COVID-19, Featured, Health, International, Local, News, Regional0 Comments

Please Support The Montserrat Reporter

This is bottom line for us! Unless we receive your support, our effort will not be able to continue. Whatever and however you can, please support The Montserrat Reporter in whatever amount you can (and whatever frequency) – and it only takes a minute.
Thank you

TMR print pages

East Caribbean Central Bank – Career Vacancies

Newsletter

Archives

FLOW - Back to School

https://indd.adobe.com/embed/2b4deb22-cf03-4509-9bbd-938c7e8ecc7d